In the BioHarmony Drug Report Database

"Preview" Icon

Mavrilimumab

Mavrilimumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against granulocyte-macrophage colony-stimulating factor receptor subunit alpha.

 

Trade Name

 

 

Common Name

 

mavrilimumab
 

ChEMBL ID

 

CHEMBL1743039
 

Indication

 

 

Drug Class

 

Monoclonal antibodies

Image (chem structure or protein)

Mavrilimumab structure rendering